Structures by: Dardouri R.
Total: 16
Ethyl {4-[(1,5-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-1<i>H</i>-1,5- benzodiazepin-3-yl)methyl]-1,2,3-triazol-1-yl}acetate
C18H21N5O4
Acta Crystallographica Section E (2010) 66, 11 o3039
a=8.5452(2)Å b=15.9993(5)Å c=13.9215(4)Å
α=90.00° β=106.8530(10)° γ=90.00°
1,3-Dimethyl-3-tetradecyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione
C25H40N2O2
Acta Crystallographica Section E (2011) 67, 3 o674
a=8.12860(10)Å b=33.5899(5)Å c=9.4095(2)Å
α=90.00° β=114.6400(10)° γ=90.00°
3-{[3-(4-Chlorophenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}-1,5-dimethyl- 1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-dione
C21H20ClN3O3
Acta Crystallographica Section E (2011) 67, 3 o720
a=8.18210(10)Å b=9.07410(10)Å c=13.3792(2)Å
α=79.7480(10)° β=80.1420(10)° γ=85.9100(10)°
3-[(1-Benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-1,5-dimethyl- 1,5-benzodiazepine-2,4-dione
C21H21N5O2
Acta Crystallographica Section E (2010) 66, 3 o632
a=8.3380(3)Å b=9.1033(3)Å c=13.4796(4)Å
α=95.385(2)° β=107.840(2)° γ=101.768(2)°
3-[(1-Benzyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-1,5-dimethyl- 1,5-benzodiazepine-2,4-dione monohydrate
C21H21N5O2,H2O
Acta Crystallographica Section E (2010) 66, 3 o633
a=9.60020(10)Å b=11.9497(2)Å c=17.0860(2)Å
α=90.00° β=92.5270(10)° γ=90.00°
1,5-Dimethyl-3-propargyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione
C14H14N2O2
Acta Crystallographica Section E (2010) 66, 7 o1797
a=16.0768(3)Å b=17.1087(3)Å c=8.9530(2)Å
α=90.00° β=93.7010(10)° γ=90.00°
1,5-Dimethyl-3-[(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)methyl]- 1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-dione
C21H21N3O3
Acta Crystallographica Section E (2010) 66, 11 o2983
a=9.3491(2)Å b=6.97220(10)Å c=27.9201(5)Å
α=90.00° β=93.1570(10)° γ=90.00°
3-(6-Bromohexyl)-1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione
C17H23BrN2O2
Acta Crystallographica Section E (2010) 66, 11 o2804
a=7.52140(10)Å b=9.3693(2)Å c=23.8686(5)Å
α=90.00° β=91.7500(10)° γ=90.00°
3-(12-Bromododecyl)-1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione
C23H35BrN2O2
Acta Crystallographica Section E (2010) 66, 11 o2805
a=7.59710(10)Å b=10.5032(2)Å c=28.7129(5)Å
α=90.00° β=95.2130(10)° γ=90.00°
7-Chloro-1,5-dipropargyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione
C15H11ClN2O2
Acta Crystallographica Section E (2010) 66, 12 o3228
a=10.7755(3)Å b=7.6580(2)Å c=16.7221(5)Å
α=90.00° β=103.6210(10)° γ=90.00°
1,3,3,5-Tetramethyl-1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-dione
C13H16N2O2
Acta Crystallographica Section E (2011) 67, 4 o783
a=7.51120(10)Å b=10.1731(2)Å c=15.8697(3)Å
α=90.00° β=103.6750(10)° γ=90.00°
3-Benzoyl-1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-\ dione
C18H16N2O3
Acta Crystallographica Section E (2011) 67, 4 o849
a=7.78270(10)Å b=23.7595(4)Å c=8.6315(2)Å
α=90.00° β=105.6140(10)° γ=90.00°
1,3-Dibenzyl-5-chloro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C21H17ClN2O
Acta Crystallographica Section E (2011) 67, 8 o2136
a=11.0380(4)Å b=9.2863(3)Å c=33.2679(13)Å
α=90.00° β=92.297(2)° γ=90.00°
3-Hexadecyl-1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione
C27H44N2O2
Acta Crystallographica Section E (2011) 67, 5 o1155
a=8.14260(10)Å b=36.2705(5)Å c=9.40900(10)Å
α=90.00° β=114.6110(10)° γ=90.00°
3-{[3-(4-Methoxyphenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}- 1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-dione
C22H23N3O4
Acta Crystallographica Section E (2011) 67, 7 o1729
a=28.0041(5)Å b=15.4644(3)Å c=9.0350(2)Å
α=90.00° β=93.2350(10)° γ=90.00°
5-Chloro-1-[(<i>E</i>)-3-(dimethylamino)acryloyl]-3-methyl-1<i>H</i>- benzimidazol-2(3<i>H</i>)-one--6-chloro-1-[(<i>E</i>)- 3-(dimethylamino)acryloyl]-3-methyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one (4/1)
C13H14ClN3O2
Acta Crystallographica Section E (2011) 67, 7 o1853
a=7.3145(2)Å b=14.2903(3)Å c=25.1512(6)Å
α=90.00° β=90.00° γ=90.00°